People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Biotech / Pharma, Pharmaceuticals, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lumicell, Inc. | — | Biotechnology | Series D+ | $331.1M | $1.7B | 2024 |
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2013 |
| Solid GT, LLC | — | Biotechnology | Series C | $42.5M | $1.7B | 2015 |
| Solid Ventures, LLC | — | Pharmaceuticals | Series B | $17.0M | $578.1M | 2013 |
| GreenLight Pandemic Response, Inc. | — | Other Technology | Series A | $8.8M | $243.4M | 2020 |
| ReviveMed, Inc. | — | Other Health Care | Seed | $1.5M | $37.2M | 2018 |
Andrey Zarur at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrey Zarur on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Furneaux | 2 | 8 |
| Ilan Ganot | 2 | 3 |
| Gilad Hayeem | 2 | 2 |
| Matthew Walker | 1 | 11 |
| Elon Boms | 1 | 10 |
| Michael Liang | 1 | 9 |
| Jonathan Fleming | 1 | 9 |
| Jason Dinges | 1 | 8 |
| Ganesh Kishore | 1 | 7 |
| Eric O'Brien | 1 | 6 |
| Martha Schlicher | 1 | 4 |
| Matthew Arnold | 1 | 4 |
| Charles L. Cooney | 1 | 4 |
| Charles Cooney | 1 | 4 |
| Neil Renninger | 1 | 4 |
| Carlos Gonzalez | 1 | 3 |
| Andrea Ponti | 1 | 2 |
| Greg Lucier | 1 | 2 |
| JAMES DAVID SCHUERMANN | 1 | 1 |
| KEVIN DAVID KRENITSKY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.